Faheem Hasnain - Nov 20, 2023 Form 4 Insider Report for Gossamer Bio, Inc. (GOSS)

Role
President & CEO, Director
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
Stock symbol
GOSS
Transactions as of
Nov 20, 2023
Transactions value $
$0
Form type
4
Date filed
11/22/2023, 07:07 PM
Previous filing
Aug 14, 2023
Next filing
Jan 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GOSS Stock Option (Right to Buy) Award $0 +438K $0.00 438K Nov 20, 2023 Common Stock 438K $0.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the total number of shares subject to the option will vest on November 20, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.